Search research articles
Contact Us
Filters
Showing results (71-80 of 130) with videos related to
Page
of 13
Sort By:
Archives of Pathology & Laboratory Medicine
|
October 2, 2009
Protocol for the examination of specimens from patients with melanoma of the skin
David P Frishberg, Charles Balch, Bonnie L Balzer, et al.
Urologic Oncology
|
July 24, 2021
Sarcomatoid features and lymph node-positive disease in chromophobe renal cell carcinoma
Alberto C Pieretti, Mary E Westerman, Alexandria Childs, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Tissue Factor Expression in Penile Squamous Cell Carcinoma: A Marker of HPV-Independent Disease
Jamaal C Jackson, Andrew C Johns, Leticia Campos Clemente, et al.
Human Pathology
|
May 1, 2014
Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder
Gladell P Paner, Chandrakanth Annaiah, Christian Gulmann, et al.
European Urology Oncology
|
July 16, 2024
Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients
Justin M Lebenthal, Panayiotis D Kontoyiannis, Andrew W Hahn, et al.
Cancers
|
November 13, 2025
Tissue Factor Expression in Penile Squamous Cell Carcinoma: A Potential Marker of HPV-Independent Disease
Jamaal C Jackson, Andrew C Johns, Leticia Campos Clemente, et al.
Human Pathology
|
September 22, 2012
Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract
Christian Gulmann, Gladell P Paner, Rugvedita S Parakh, et al.
Clinical Genitourinary Cancer
|
February 21, 2017
Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era
Sarathi Kalra, Jonathan Verma, Bradley J Atkinson, et al.
Cancers
|
May 5, 2021
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma
Andrew J Wiele, Devaki Shilpa Surasi, Priya Rao, et al.
Cancers
|
March 13, 2024
Transcriptomic, Proteomic, and Genomic Mutational Fraction Differences Based on HPV Status Observed in Patient-Derived Xenograft Models of Penile Squamous Cell Carcinoma
Niki M Zacharias, Luis Segarra, Keiko Akagi, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 130) with videos related to
Sort By:
Page
of 13
Archives of Pathology & Laboratory Medicine
|
October 2, 2009
Protocol for the examination of specimens from patients with melanoma of the skin
David P Frishberg, Charles Balch, Bonnie L Balzer, et al.
Urologic Oncology
|
July 24, 2021
Sarcomatoid features and lymph node-positive disease in chromophobe renal cell carcinoma
Alberto C Pieretti, Mary E Westerman, Alexandria Childs, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Tissue Factor Expression in Penile Squamous Cell Carcinoma: A Marker of HPV-Independent Disease
Jamaal C Jackson, Andrew C Johns, Leticia Campos Clemente, et al.
Human Pathology
|
May 1, 2014
Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder
Gladell P Paner, Chandrakanth Annaiah, Christian Gulmann, et al.
European Urology Oncology
|
July 16, 2024
Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients
Justin M Lebenthal, Panayiotis D Kontoyiannis, Andrew W Hahn, et al.
Cancers
|
November 13, 2025
Tissue Factor Expression in Penile Squamous Cell Carcinoma: A Potential Marker of HPV-Independent Disease
Jamaal C Jackson, Andrew C Johns, Leticia Campos Clemente, et al.
Human Pathology
|
September 22, 2012
Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract
Christian Gulmann, Gladell P Paner, Rugvedita S Parakh, et al.
Clinical Genitourinary Cancer
|
February 21, 2017
Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era
Sarathi Kalra, Jonathan Verma, Bradley J Atkinson, et al.
Cancers
|
May 5, 2021
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma
Andrew J Wiele, Devaki Shilpa Surasi, Priya Rao, et al.
Cancers
|
March 13, 2024
Transcriptomic, Proteomic, and Genomic Mutational Fraction Differences Based on HPV Status Observed in Patient-Derived Xenograft Models of Penile Squamous Cell Carcinoma
Niki M Zacharias, Luis Segarra, Keiko Akagi, et al.
Page
of 13